CRISPR Therapeutics AG (CRSP)
49.39
-0.60
(-1.20%)
USD |
NASDAQ |
Oct 23, 16:00
49.07
-0.32
(-0.65%)
After-Hours: 20:00
CRISPR Therapeutics Price : 49.39 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 49.31 | 49.68 | 48.02 | 49.39 | 1.926M |
| Oct 22, 2026 | 50.14 | 51.05 | 49.36 | 49.99 | 906107.0 |
| Oct 21, 2026 | 50.13 | 50.94 | 49.55 | 50.50 | 1.171M |
| Oct 20, 2026 | 48.87 | 50.33 | 47.36 | 49.88 | 2.156M |
| Oct 19, 2026 | 49.83 | 50.30 | 49.09 | 50.04 | 1.177M |
| Oct 16, 2026 | 51.20 | 51.36 | 49.04 | 49.25 | 1.525M |
| Oct 15, 2026 | 50.00 | 52.37 | 49.76 | 51.52 | 1.353M |
| Oct 14, 2026 | 49.67 | 50.78 | 48.91 | 50.22 | 1.708M |
| Oct 13, 2026 | 51.01 | 51.11 | 49.77 | 50.10 | 1.343M |
| Oct 12, 2026 | 52.91 | 53.21 | 51.40 | 51.55 | 1.106M |
| Oct 09, 2026 | 50.82 | 54.07 | 50.52 | 53.39 | 1.472M |
| Oct 08, 2026 | 51.51 | 53.54 | 50.02 | 50.44 | 2.867M |
| Oct 07, 2026 | 53.00 | 54.59 | 52.27 | 52.35 | 1.680M |
| Oct 06, 2026 | 60.38 | 60.68 | 53.74 | 54.00 | 2.628M |
| Oct 05, 2026 | 55.21 | 57.46 | 54.01 | 57.34 | 1.703M |
| Oct 02, 2026 | 56.45 | 57.58 | 54.09 | 55.43 | 1.131M |
| Oct 01, 2026 | 55.44 | 56.59 | 54.82 | 55.44 | 1.058M |
| Sep 30, 2026 | 56.55 | 57.11 | 55.28 | 55.32 | 1.169M |
| Sep 29, 2026 | 54.08 | 56.48 | 54.00 | 56.00 | 1.577M |
| Sep 28, 2026 | 53.84 | 55.63 | 52.90 | 54.09 | 1.271M |
| Sep 25, 2026 | 56.14 | 56.39 | 53.92 | 54.23 | 1.009M |
| Sep 24, 2026 | 54.95 | 57.17 | 53.79 | 55.70 | 1.556M |
| Sep 23, 2026 | 59.10 | 59.52 | 54.67 | 55.76 | 2.363M |
| Sep 22, 2026 | 58.73 | 60.72 | 57.64 | 59.03 | 2.084M |
| Sep 21, 2026 | 57.98 | 59.24 | 56.87 | 58.33 | 1.814M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 523.93 |
| Basilea Pharmaceutica AG | 76.25 |
| Santhera Pharmaceuticals Holding AG | 18.30 |
| BeOne Medicines Ltd. | 377.63 |
| Intellia Therapeutics, Inc. | 11.21 |
Price Related Metrics
| PS Ratio | 349.57 |
| Price to Book Value | 2.733 |
| Earnings Yield | -9.64% |
| Market Cap | 4.774B |